Comparison of treatment efficacy of targeted therapies approved in China for non-small cell lung cancer before and after the introduction of accelerated drug marketing registration procedures
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International journal of clinical pharmacy
- Publicado em
- 17 mar 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Comparison of treatment efficacy of targeted therapies approved in China for non-small cell lung cancer before and after the introduction of accelerated drug marketing registration procedures
Chenning Liu, Liyang Lyu, Yufan Zhang, Yingyi Tian, Jing Yuan, Chihua Li, Yuanjia Hu
Descritores MeSH
- Molecular Targeted Therapy
- Antineoplastic Agents
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Drug Approval
- Progression-Free Survival
- Retrospective Studies
- Treatment Outcome
- China
- Humans